Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nele Festjens

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancers|December 10, 2021
T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell TherapyElien De Bousser, Nico Callewaert, Nele Festjens
Biochimica Et Biophysica Acta|September 5, 2006
Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune responseNele Festjens, Tom Vanden Berghe, Peter Vandenabeele
Science'S STKE : Signal Transduction Knowledge Environment|October 26, 2006
Caspase inhibitors promote alternative cell death pathwaysPeter Vandenabeele, Tom Vanden Berghe, Nele Festjens
The FEBS Journal|August 17, 2019
A guide to Mycobacterium mutagenesisKatlyn Borgers, Kristof Vandewalle, Nele Festjens, et al.
Biological Chemistry|August 10, 2006
Caspase-containing complexes in the regulation of cell death and inflammationNele Festjens, Sigrid Cornelis, Mohamed Lamkanfi, et al.
Biological Chemistry|February 5, 2010
Glycome profiling using modern glycomics technology: technical aspects and applicationsDieter Vanderschaeghe, Nele Festjens, Joris Delanghe, et al.
Cellular and Molecular Life Sciences : CMLS|March 4, 2010
Tumor necrosis factor-mediated cell death: to break or to burst, that's the questionFranky Van Herreweghe, Nele Festjens, Wim Declercq, et al.
Human Vaccines & Immunotherapeutics|March 19, 2020
Human T cell glycosylation and implications on immune therapy for cancerElien De Bousser, Leander Meuris, Nico Callewaert, et al.
Current Pharmaceutical Design|February 22, 2007
Inflammatory caspases: targets for novel therapiesSigrid Cornelis, Kristof Kersse, Nele Festjens, et al.
Current Molecular Medicine|May 14, 2008
Molecular mechanisms and pathophysiology of necrotic cell deathNele Vanlangenakker, Tom Vanden Berghe, Dmitri V Krysko, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancers|December 10, 2021
T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell TherapyElien De Bousser, Nico Callewaert, Nele Festjens
Biochimica Et Biophysica Acta|September 5, 2006
Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune responseNele Festjens, Tom Vanden Berghe, Peter Vandenabeele
Science'S STKE : Signal Transduction Knowledge Environment|October 26, 2006
Caspase inhibitors promote alternative cell death pathwaysPeter Vandenabeele, Tom Vanden Berghe, Nele Festjens
The FEBS Journal|August 17, 2019
A guide to Mycobacterium mutagenesisKatlyn Borgers, Kristof Vandewalle, Nele Festjens, et al.
Biological Chemistry|August 10, 2006
Caspase-containing complexes in the regulation of cell death and inflammationNele Festjens, Sigrid Cornelis, Mohamed Lamkanfi, et al.
Biological Chemistry|February 5, 2010
Glycome profiling using modern glycomics technology: technical aspects and applicationsDieter Vanderschaeghe, Nele Festjens, Joris Delanghe, et al.
Cellular and Molecular Life Sciences : CMLS|March 4, 2010
Tumor necrosis factor-mediated cell death: to break or to burst, that's the questionFranky Van Herreweghe, Nele Festjens, Wim Declercq, et al.
Human Vaccines & Immunotherapeutics|March 19, 2020
Human T cell glycosylation and implications on immune therapy for cancerElien De Bousser, Leander Meuris, Nico Callewaert, et al.
Current Pharmaceutical Design|February 22, 2007
Inflammatory caspases: targets for novel therapiesSigrid Cornelis, Kristof Kersse, Nele Festjens, et al.
Current Molecular Medicine|May 14, 2008
Molecular mechanisms and pathophysiology of necrotic cell deathNele Vanlangenakker, Tom Vanden Berghe, Dmitri V Krysko, et al.
Pageof 3